K-Clip
Commercial- Indications
- Tricuspid regurgitation
Company intelligence / Profile preview
Huihe Medical has developed the K‑Clip annuloplasty system, a minimally invasive transcatheter device designed to treat severe tricuspid regurgitation. In first-in-human studies of the K‑Clip involving patients with severe TR, procedural success was reported at 100% with no major adverse cardiovascular events at one month. Echocardiography showed significant reductions in annular circumference and area, and patient quality-of-life scores improved markedly. Larger studies and longer-term follow-up are needed before widespread adoption.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huihe Medical.